One of the most common causes of thrombocytopenia, immune thrombocytopenic purpura (ITP), can cause a severe reduction in the circulating platelet count, with a subset of affected individuals not ...

More information: Zhangbiao Long et al, Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated ...

The 42-year-old presenter has Immune thrombocytopenic purpura (ITP), a rare blood disorder that results in low platelet levels, often causing excessive bruising. Laura, has spoken openly about ...

The 42-year-old TV presenter suffers from Immune thrombocytopenic purpura (ITP), a disorder that results in low platelet levels, often causing excessive bruising. Despite the effects of the ...

which examined the use of obinutuzumab in patients with thrombotic thrombocytopenic purpura. Sosa, an associate professor and chief of the division of hematology at Fox Chase Cancer Center ...

U.S.-based biotech builder Mountainfield Venture Partners and China’s Keymed Biosciences have launched a new company armed ...

Immune globulin (human) is under clinical development by Grifols and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Zanubrutinib is under clinical development by BeiGene and currently in Phase II for Lupus Nephritis. According to GlobalData, Phase II drugs for Lupus Nephritis have a 50% phase transition success ...